Pfizer vaccine for adolescents to get FDA approval; much-anticipated decision opens door for 12-15 year-olds
Published
The Food and Drug Administration is likely to authorize the Pfizer-BioNTech COVID-19 vaccine for adolescents within the next week, according to the New York Times and CNN.